Next |
home / stock / abt / abt message board
Subject | By | Source | When |
---|---|---|---|
$ABT 1Q23 CC transcript: | DewDiligence | investorshub | 04/20/2023 3:39:39 PM |
$ABT 1Q23 Results by Business Segment | DewDiligence | investorshub | 04/19/2023 3:45:11 PM |
$ABT reports 1Q23 resultsslightly increases 2023 guidance: | DewDiligence | investorshub | 04/19/2023 3:44:34 PM |
whytestocks: $ABT News Article - Abbott Laboratories (NYSE: ABT) is a Leading Gainer in Wednesday Mo | whytestocks | investorshangout | 04/19/2023 3:35:46 PM |
FreeStyle Libre gets expanded Medicare coverage: | DewDiligence | investorshub | 04/17/2023 4:17:29 PM |
FDA clears $ABT's standalone glucose reader from FreestyleLibre: | DewDiligence | investorshub | 04/14/2023 2:06:15 PM |
FDA enables integration of FreeStyle Libre with automated insulin delivery syste | DewDiligence | investorshub | 03/06/2023 5:20:07 PM |
$ABT TriClip (tricuspid-value clip) highlighted at ACC | DewDiligence | investorshub | 03/06/2023 1:15:06 AM |
$ABT acquires CSII for $20/sh casha 50% premium | DewDiligence | investorshub | 02/08/2023 11:23:33 PM |
$ABT reports 4Q22 resultsissues 2023 guidance: | DewDiligence | investorshub | 01/25/2023 1:58:21 PM |
$ABT CEO at$ JPM: Libre will become a | DewDiligence | investorshub | 01/10/2023 5:23:24 PM |
$ABT increases dividend for 51st(!) consecutive year: | DewDiligence | investorshub | 12/09/2022 6:34:55 PM |
$ABT 3Q22 CC transcript: | DewDiligence | investorshub | 10/19/2022 11:34:13 PM |
Yes sir Dew, I was nit taking a | wiwineguy | investorshub | 10/19/2022 1:57:13 PM |
From my post earlier today: The stock is | DewDiligence | investorshub | 10/19/2022 1:52:55 PM |
And yet its selling off like crazy | wiwineguy | investorshub | 10/19/2022 1:47:41 PM |
$ABT 3Q22 Results by Business Segment | DewDiligence | investorshub | 10/19/2022 1:31:25 PM |
$ABT reports 3Q22 resultsraises 2022 EPS guidance: | DewDiligence | investorshub | 10/19/2022 1:30:52 PM |
$ABTs TCT presentations: | DewDiligence | investorshub | 09/19/2022 12:12:53 AM |
$ABT 2Q22 CC transcript: | DewDiligence | investorshub | 07/20/2022 4:54:05 PM |
News, Short Squeeze, Breakout and More Instantly...
Abbott Laboratories Company Name:
ABT Stock Symbol:
NYSE Market:
NORTHAMPTON, MA / ACCESSWIRE / April 23, 2024 / Abbott Eleven new HeartMates with 11 inspiring stories recognized at Abbott HeartMates Draft Day event in NYC. Abbott Just a week before the pro football draft, Abbott held a high-profile draft day experience for our HeartMates program. Hos...
2024-04-18 23:00:03 ET Lee Hambright from Bernstein issued a price target of $133.00 for ABT on 2024-04-18 21:44:00. The adjusted price target was set to $133.00. At the time of the announcement, ABT was trading at $105.27. The overall price target consensus is at $129.8...
2024-04-18 08:15:07 ET RBC Capital analyst issues OUTPERFORM recommendation for ABT on April 18, 2024 06:19AM ET. The previous analyst recommendation was Outperform. ABT was trading at $105.9 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...